Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-Dose Levonorgestrel with EFV or RIF
NCT03819114Phase 2Completed
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, open-label trial of avatrombopag in unintended pregnancy (4 arms). Primary endpoint: LNG Area Under the Concentration-time Curve (AUC0-8h). Started May 2019; status: completed.
02
Drugs
avatrombopag
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT03819114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03819114.